1. Home
  2. EBS vs EAD Comparison

EBS vs EAD Comparison

Compare EBS & EAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EBS
  • EAD
  • Stock Information
  • Founded
  • EBS 1998
  • EAD 2003
  • Country
  • EBS United States
  • EAD United States
  • Employees
  • EBS N/A
  • EAD N/A
  • Industry
  • EBS Biotechnology: Pharmaceutical Preparations
  • EAD Finance/Investors Services
  • Sector
  • EBS Health Care
  • EAD Finance
  • Exchange
  • EBS Nasdaq
  • EAD Nasdaq
  • Market Cap
  • EBS 359.3M
  • EAD 416.0M
  • IPO Year
  • EBS 2006
  • EAD N/A
  • Fundamental
  • Price
  • EBS $7.16
  • EAD $7.02
  • Analyst Decision
  • EBS Strong Buy
  • EAD
  • Analyst Count
  • EBS 3
  • EAD 0
  • Target Price
  • EBS $14.33
  • EAD N/A
  • AVG Volume (30 Days)
  • EBS 1.4M
  • EAD 178.9K
  • Earning Date
  • EBS 08-06-2025
  • EAD 01-01-0001
  • Dividend Yield
  • EBS N/A
  • EAD 8.91%
  • EPS Growth
  • EBS N/A
  • EAD N/A
  • EPS
  • EBS N/A
  • EAD N/A
  • Revenue
  • EBS $965,400,000.00
  • EAD N/A
  • Revenue This Year
  • EBS N/A
  • EAD N/A
  • Revenue Next Year
  • EBS $16.15
  • EAD N/A
  • P/E Ratio
  • EBS N/A
  • EAD N/A
  • Revenue Growth
  • EBS N/A
  • EAD N/A
  • 52 Week Low
  • EBS $4.02
  • EAD $5.69
  • 52 Week High
  • EBS $15.10
  • EAD $6.81
  • Technical
  • Relative Strength Index (RSI)
  • EBS 53.48
  • EAD 51.72
  • Support Level
  • EBS $6.89
  • EAD $6.95
  • Resistance Level
  • EBS $7.83
  • EAD $7.05
  • Average True Range (ATR)
  • EBS 0.37
  • EAD 0.06
  • MACD
  • EBS -0.00
  • EAD -0.02
  • Stochastic Oscillator
  • EBS 42.80
  • EAD 47.83

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

About EAD Allspring Income Opportunities Fund

Allspring Income Opportunities Fund is a diversified closed-end management investment company. Its products and services are mutual funds, closed-end funds, managed accounts services, and variable trust funds. The fund's objective is a high level of current income and capital appreciation. Its portfolio of investments is Commercial services, healthcare services, Food, Pharmaceuticals, Energy, Oil & gas, Pipelines, Diversified financial services, and Others.

Share on Social Networks: